EGFR and non-small cell lung carcinoma: advanced (stage IIIB/IV or recurrent) EGFR‐mutated (ex19del or L858R mutation, with or without T790 M) NSCLC, aged≥18 years, ECOG 0–1, newly diagnosed, without CNS metastases